4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-008095
President and CEO sold 50,000 shares at an average $41.11 ($2,055,576)
- President and CEO acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Torley Helen · President and CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-10 | Exercise or conversion : show line 1 in the form | +50,000 | $14.66 | $733,000 | 587,160 | D |
| 2021-08-10 | Sale : show line 2 in the form | −25,138 | $40.42 | $1,016,103 | 562,022 | D |
| 2021-08-10 | Sale : show line 3 in the form | −21,914 | $41.47 | $908,752 | 540,108 | D |
| 2021-08-10 | Sale : show line 4 in the form | −1,000 | $42.64 | $42,640 | 539,108 | D |
| 2021-08-10 | Sale : show line 5 in the form | −400 | $43.26 | $17,304 | 538,708 | D |
| 2021-08-10 | Sale : show line 6 in the form | −500 | $44.91 | $22,454 | 538,208 | D |
| 2021-08-10 | Sale : show line 7 in the form | −1,048 | $46.11 | $48,323 | 537,160 | D |
| Open-market sales · 50,000 sh · avg $41.11 · $2,055,576 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2021-08-10 | Exercise or conversion : show line 8 in the form Option to Purchase Common Stock | −50,000 | $14.66 | $733,000 | $14.66 | 2024-01-06 | 50,000 | 300,000 | D |
Loading xslF345X03/edgar.xml…